David C Volz Selected Research

Cestode Infections (Tapeworm Infection)

10/2019	Maternal-to-zygotic transition as a potential target for niclosamide during early embryogenesis.
12/2018	Niclosamide Induces Epiboly Delay During Early Zebrafish Embryogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David C Volz Research Topics

Disease

6	Cardiotoxicity 10/2021 - 05/2013
4	Edema (Dropsy) 01/2022 - 01/2019
4	Neoplasms (Cancer) 01/2021 - 01/2005
2	Cestode Infections (Tapeworm Infection) 10/2019 - 12/2018
2	Bacterial Infections (Bacterial Infection) 10/2019 - 12/2018
2	Congenital Abnormalities (Deformity) 08/2017 - 05/2017
2	Anemia 01/2015 - 01/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Bradycardia 01/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Obesity 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2019
1	Variegate Porphyria (Protoporphyrinogen Oxidase Deficiency) 01/2015
1	Body Weight (Weight, Body) 05/2005
1	Male Infertility (Male Sterility) 01/2004

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2022 - 12/2018
2	Mannitol (Osmitrol)FDA LinkGeneric 01/2022 - 01/2019
2	triphenyl phosphateIBA 01/2022 - 01/2018
2	Niclosamide FDA Link 10/2019 - 12/2018
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 07/2019 - 01/2018
2	FenretinideIBA 07/2019 - 01/2018
2	butafenacilIBA 01/2015 - 01/2014
2	Phosphates (Orthophosphate)IBA 09/2014 - 05/2013
1	ATPase Inhibitory ProteinIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	EnzymesIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	bisphenol AIBA 01/2022
1	Osmotic DiureticsIBA 01/2022
1	Ouabain (G Strophanthin)IBA 01/2022
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 10/2021
1	Benzo(a)pyreneIBA 10/2021
1	Ion Channels (Ion Channel)IBA 10/2021
1	SolutionsIBA 10/2021
1	2- chloro- N- (4- chlorobiphenyl- 2- yl)nicotinamideIBA 01/2021
1	CholesterolIBA 01/2021
1	Benzene (Benzole)IBA 01/2021
1	ThiazolidinedionesIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Petroleum (Crude Oil)IBA 01/2021
1	Formaldehyde poisoningIBA 01/2021
1	phenanthreneIBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2018
1	LigandsIBA 01/2018
1	ciglitazoneIBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	PPAR gammaIBA 01/2018
1	Estrogen Receptor AntagonistsIBA 05/2017
1	Fulvestrant (Faslodex)FDA Link 05/2017
1	protoporphyrin IXIBA 01/2015
1	MorpholinosIBA 09/2014
1	Firemaster 550IBA 09/2014
1	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 09/2014
1	Protein Isoforms (Isoforms)IBA 09/2014
1	DianisidineIBA 01/2014
1	Hemoglobins (Hemoglobin)IBA 01/2014
1	HerbicidesIBA 01/2014
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 05/2013
1	EstersIBA 05/2013
1	Polychlorinated Dibenzodioxins (TCDD)IBA 05/2005
1	Biomarkers (Surrogate Marker)IBA 01/2005
1	InsecticidesIBA 01/2004
1	fipronilIBA 01/2004

Therapy/Procedure

1	Aftercare (After-Treatment) 08/2017